The cerebral glucose metabolism of eight patients with schizophrenia and an olfactory agnosia was compared with that of eight normosmic patients with schizophrenia and eight normal controls. Since all patients were scanned while on their current medication regimen, the duration and dosage of the medication of the two patient groups were compared. Similarly, duration and dosage were correlated with absolute regional metabolic rates. No significant effects were found in these analyses. The patients with schizophrenia had significantly lower rates of frontal metabolism than the normal controls. However, the patients with schizophrenia and an olfactory agnosia had a lower right basal ganglia and thalamic metabolism than the normosmic patients with schizophrenia.
References
1.
HurwitzT., KopalaL., ClarkC.Olfactory deficits in schizophrenia.Biol Psychiatry1988; 23(2): 123–128.
2.
KopalaL., ClarkC., HurwitzT.Sex differences in olfactory function in schizophrenia.Am J Psychiatry1989; 146: 1320–1322.
3.
WarnerM., PeabodyC., CsernanskyJ.Olfactory functioning in schizophrenia and depression.Biol Psychiatry1990; 27: 457–458.
4.
HurwitzT., ClarkC.Response to Warner et al.Biol Psychiatry1990; 27: 458.
5.
JonesB., MoskowitzH., ButtersW.Olfactory discrimination in alcoholic Korsakoff's patients.Neuropsychologia1975; 13: 173–179.
6.
MairR., McEnteeW., DotyR.Olfactory perception in Korsakoff's psychosis: correlation with brain noradrenergic activity.Neurology1983; 33: 64–65.
7.
Jones-GotmanM., ZatorreR.Olfactory identification deficits in patients with focal cerebral excision.Neuropsychologia1988; 26(3): 387–400.
8.
DotyR., DeemsD., StellarS.Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage or disease duration.Neurology1988; 38: 1237–1244.
9.
MobergP., PearlsonG., SpeedieL.Olfactory recognition: differential impairments in early and late Huntington's and Alzheimer's disease.J Clin Exp Neuropsychol1989; 9: 650–664.
10.
PanskyB., AllenD.Review of neuroscience.New York: Macmillan,1980.
11.
StevensJ.Neurology and neuropathology of schizophrenia. In: HennF., NasrallahH., eds. Schizophrenia as brain disease.New York: Oxford University Press, 1982.
12.
WeinbergerD., WagnerR., WyattR.Neuropathological studies of schizophrenia: a selective review.Schizophr Bull1983; 9: 193–212.
13.
FalkaiP., BogertsB., RozumekM.Limbic pathology in schizophrenia: the entorhinal region — a morphometric study.Biol Psychiatry1988; 24; 515–521.
14.
KleinmanJ., CasanovaM., JaskiwG.The neuropathology of schizophrenia.Schizophr Bull1988; 14: 209–216.
15.
BrodieJ., ChristmanD., CoronaJ.Patterns of metabolic activity in the treatment of schizophrenia.Ann Neurol1984 (Suppl); 15: S166–S169.
16.
BuchsbaumM., IngvarD., KesslerR.Cerebral glucography with positron tomography.Arch Gen Psychiatry1982; 39: 251–259.
17.
WolkinA., JaegerJ., BrodieJ.Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography.Am J Psychiatry1985; 142: 564–571.
18.
WeinbergerD.Schizophrenia and the frontal lobes.Trends in Neuroscience1988; 11: 367–370.
19.
Diagnostic and statistical manual of mental disorders, third edition, revised.Washington DC: American Psychiatric Press, Inc.,1987.
20.
Manual of international classification of diseases, injuries, and causes of death, ninth revision.Geneva: World Health Organization, 1975.
21.
DotyR., ShamanP., DannM.Development of the University of Pennsylvania Smell Test: standardized micro encapsulated test of olfactory function.Physiology Behav1984; 32: 489–502.
22.
EndicottJ., SpitzerR., FleissJ.The Global Assessment Scale: a procedure for measuring overall sensitivity of psychiatric disturbance.Arch Gen Psychiatry1976; 33: 766–771.
23.
EvansB., HarropR., HeywoodD.Engineering developments on the UBC-TRIUMF modified PETT VI positron emission tomograph.IEEE Transaction of Nuclear Science1983; NS30: 707–710.
24.
SokoloffL., ReivichM., KennedyC.The 14C deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure and normal values in the conscious anaesthetized albino rat.J Neurochem1977; 28: 897–916.
25.
BrooksR.Alternative formula for glucose utilization using labelled deoxyglucose.J Nucl Med1982; 23: 538–539.
26.
HuangS., PhelpsM., HoffmanE.Noninvasive determination of local cerebral metabolic rate of glucose in man.American Journal of Physiology (Endocrinol Metab)1980; 238: E69–E82.
27.
PardridgeW., CraneP., MietusL.Kinetics of regional blood-brain barrier transport and brain phosphorylation of glucose and 2deoxyglucose in the barbiturate-anaesthetized rat.J Neurochem1982; 38: 560–568.
28.
ClarkC.Minority opinion on the extraction of regional values from functional brain images.J Cereb Blood Flow Metab1987; 7(2): S13–S16.
29.
ClarkC., StoesslA.Glucose use correlations: a matter of inference.J Cereb Blood Flow Metab1986; 6: 511–512.
30.
DeLisiL., HolcombH., CohenR.Positron emission tomography in schizophrenic patients with and without neuroleptic medication.J Cereb Blood Flow Metab1985; 5: 201–206.
31.
SzechtmanH., NahmaisC., GarnetS.Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia.Arch Gen Psychiatry1988; 45: 523–532.
32.
GurR., ResnickS., AbassA.Regional brain function in schizophrenia I and II.Arch Gen Psychiatry1987; 44: 119–125, 126–129.
33.
FarkasT., ReivichM., AlaviA.et al. The application of [18F]2-deoxy-2-fluor-D-glucose and positron emission tomography in the study of psychiatric conditions. In: PassoneauJ., HawkinR., LustW., eds. Cerebral metabolism and neural function.Baltimore MD: Williams and Wilkins Press, 1980.
